Navigation Links
Steroid Treatment after head injury may be fatal

According to a report from Lancet, Patients with head injury who were treated with methylprednisolone had a significantly increased risk of death within //the following 2 weeks compared with untreated group of patients.

"Our early results show that corticosteroids should not be used routinely to treat head injury, whatever the severity," Dr. Ian Roberts. He is clinical coordinator of the CRASH (corticosteroid randomization after significant head injury) trial. In 1997, a systematic review suggested the risk of death could be reduced by up to 2% by treating head injury victims with steroids, the CRASH trial collaborators note. However, the 95% confidence interval ranged between 6% fewer to 2% more deaths.

CRASH was supposed to enrol 20,000 patients with Glasgow coma score of 14 or lower within 8 hours of head injury. However after studying 10,008 patients in 239 hospitals from 49 countries the trail found 21% mortality rate within 2 weeks for those treated with the 48-hour methylprednisolone infusion, versus 18% among those allocated placebo (relative risk 1.18, p = 0.0001).

"The relative increase in deaths due to corticosteroids did not differ by injury severity (p = 0.22) or time since injury (p = 0.05)," the authors note.

"By clearly refuting a mortality benefit from corticosteroids in head injury, the CRASH trial results should protect many thousands of patients from any increased risk of death associated with these drugs," they add. These findings could have similar implications for use of corticosteroids in spinal cord injury.

The lesson learnt from CRASH according to Dr. Stefan Sauerland, at the University of Cologne, and Dr. Marc Maegele at the University of Witten-Herdecke, in Germany, is that "we should avoid trusting in underpowered clinical trials with surrogate rather than clinical endpoints, and transferring evidence from one disease to another."


'"/>




Page: 1

Related medicine news :

1. Inhaled Steroids Safe & Effective for Children with Asthma
2. Mislabeled Body-building Steroid Supplements
3. Steroid Treatment for Wheezing Questioned
4. Steroid-Free Liver Transplants
5. The Use Of Steroids for Dizziness Questioned
6. Biofeedback Found To Reduce Steroid Dependence In Asthmatics
7. The Link Between High-dose Steroid Use And Heart Disease Questioned
8. The Use Of Oral Steroids For Muscular Dystrophy Questioned
9. No Steroids for Traumatic Brain Injury
10. Steroids Effective For Treating Carpel Tunnel Syndrome
11. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
(Date:10/12/2017)... Miramar, FL (PRWEB) , ... October 12, 2017 ... ... is presenting the latest in wound care advancements to physician colleagues, skilled nursing ... lecture is titled, "Navigating the Treacherous Waters of Wound Care." , "At many ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:10/2/2017)... Oct. 2, 2017  AllianceRx Walgreens Prime, the combined ... Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), ... which included the unveiling of new signage at its ... well as at a few other company-owned facilities across ... to patients, some of whom will begin to see ...
(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...
Breaking Medicine Technology: